Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Logo PMI - Precision Medicine in Chronic Inflammation

Cluster news

Maus

Wild animals allow new insights into the skin microbiome

Kiel research team describes for the first time differences in the bacterial colonization of the skin in house and laboratory mice as a basis for future improved dermatological models

 
group picture

COVID-19: First large genome-wide study worldwide on risk genes

Research team from Kiel finds gene variants for severe course of Covid-19: The blood group might have an influence on the severity of Covid-19 symptoms.

 
portrait picture

Professor Thomas F. Meyer receives the Robert Koch Gold Medal for his life's work

This year, one of the highest awards in infection biology goes to the future Kiel senior professor

 
Researchers in white coats stand at sequencers in a laboratory

Comprehensive genetic characterization of primary immunodeficiency

International research team involving the Cluster of Excellence PMI explores the genetics of primary immunodeficiencies (PID) on an unprecedented scale